Loading company…
NeoX Biotech is a Beijing biopharmaceutical company developing macromolecular and multispecific drugs for immuno-oncology.
Established in 2018 and based in Beijing, China, NeoX Biotech was founded by Dr. Hang Chen, who holds a Ph.D. in physical chemistry from MIT. Its neoPlatform combines AI, computational biophysics and high-throughput experimental data to target protein-protein interactions across nanobodies, fusion proteins, bispecific antibodies and protein degraders. The company closed a Series A+ round in July 2021 and earns revenue through its pipeline and partnerships with pharmaceutical companies.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in